Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010

Details

• Alternative Title:
  Open Forum Infect Dis
• Personal Author:
  Lebo, Emmaculate J. ; Kruszon-Moran, Deanna M. ; Marin, Mona ; Bellini, William J. ; Schmid, Scott ; Bialek, Stephanie R. ; Wallace, Gregory S. ; McLean, Huong Q.
• Description:
   In the United States, measles, mumps, rubella, and varicella immunity is now primarily achieved through vaccination. Monitoring population immunity is necessary.| We evaluated seroprevalence of antibodies to measles, mumps, rubella, and varicella using the National Health and Nutrition Examination Survey during 2009–2010.| Measles, mumps, rubella, and varicella seroprevalence was 92.0% (95% confidence interval [CI], 90.9%−93.0%), 87.6% (CI, 85.8%−89.2%), 95.3% (CI, 94.3%−96.2%), and 97.8% (CI, 97.1%−98.3%), respectively. United States (US)-born persons had lower mumps seroprevalence and higher varicella seroprevalence than non-US born persons.| Seroprevalence was high (88%–98%) for all 4 viruses in the US population during 2009−2010.
• Subjects:
  Antibodies Brief Reports Chickenpox Measles Mumps NHANES Rubella Seroepidemiologic Studies.
• Source:
  Open Forum Infect Dis. 2015; 2(1).
• Document Type:
  Journal Article
• Volume:
  2
• Issue:
  1
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:57c0f1d5b04feeacf62ec84d39f67ac7b91f15522eac24a908486a139b0fe5d2
• Download URL:
  https://stacks.cdc.gov/view/cdc/31346/cdc_31346_DS1.pdf
• File Type:
  [PDF - 147.36 KB ]